Pembrolizumab: a new Drug That Can Induce Exacerbations of Psoriasis

Actas Dermosifiliogr. 2016 Apr;107(3):264-6. doi: 10.1016/j.ad.2015.07.012. Epub 2015 Nov 3.

[Article in English, Spanish]

Authors

A Sahuquillo-Torralba¹, R Ballester-Sánchez², C Pujol-Marco², R Botella-Estrada²

Affiliations

¹ Servicio de Dermatología, Hospital Universitari i Politécnic La Fe, Universidad de Valencia, Valencia, España. Electronic address: [email protected].
² Servicio de Dermatología, Hospital Universitari i Politécnic La Fe, Universidad de Valencia, Valencia, España.

PMID: 26546027
DOI: 10.1016/j.ad.2015.07.012

No abstract available

Publication types

Case Reports

MeSH terms

Antibodies, Monoclonal, Humanized / adverse effects*
Humans
Psoriasis / chemically induced*

Substances

Antibodies, Monoclonal, Humanized
pembrolizumab